Rachel Webb

1.3k total citations
57 papers, 671 citations indexed

About

Rachel Webb is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Infectious Diseases. According to data from OpenAlex, Rachel Webb has authored 57 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Public Health, Environmental and Occupational Health, 25 papers in Epidemiology and 16 papers in Infectious Diseases. Recurrent topics in Rachel Webb's work include Streptococcal Infections and Treatments (30 papers), Infective Endocarditis Diagnosis and Management (17 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Rachel Webb is often cited by papers focused on Streptococcal Infections and Treatments (30 papers), Infective Endocarditis Diagnosis and Management (17 papers) and Antimicrobial Resistance in Staphylococcus (8 papers). Rachel Webb collaborates with scholars based in New Zealand, United States and Australia. Rachel Webb's co-authors include Nigel Wilson, Thomas L. Gentles, Nicole J. Moreland, Adrian Trenholme, John W. Stirling, Diana Lennon, Clare O’Donnell, Susan Taylor, Eduardo A. Tovar and Jeffrey R. Dell and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and Emerging infectious diseases.

In The Last Decade

Rachel Webb

52 papers receiving 658 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rachel Webb New Zealand 14 361 290 283 93 91 57 671
Jeffrey Cannon Australia 18 497 1.4× 297 1.0× 261 0.9× 37 0.4× 63 0.7× 55 725
Andrew E. Warren Canada 15 497 1.4× 219 0.8× 240 0.8× 181 1.9× 149 1.6× 51 946
V. Fan Tait United States 3 460 1.3× 248 0.9× 163 0.6× 26 0.3× 64 0.7× 6 752
Brenna Anderson United States 19 202 0.6× 192 0.7× 562 2.0× 97 1.0× 21 0.2× 49 903
Seilesh Kadambari United Kingdom 20 156 0.4× 399 1.4× 651 2.3× 50 0.5× 192 2.1× 54 1.0k
Ronald H. Dallas United States 14 148 0.4× 259 0.9× 159 0.6× 54 0.6× 20 0.2× 33 638
Barry Dashefsky United States 16 302 0.8× 189 0.7× 477 1.7× 184 2.0× 23 0.3× 29 954
Anne M. Hause United States 21 159 0.4× 768 2.6× 275 1.0× 77 0.8× 120 1.3× 34 1.1k
Bo Reményi Australia 19 1.1k 3.0× 521 1.8× 717 2.5× 90 1.0× 358 3.9× 44 1.4k

Countries citing papers authored by Rachel Webb

Since Specialization
Citations

This map shows the geographic impact of Rachel Webb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Webb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Webb more than expected).

Fields of papers citing papers by Rachel Webb

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Webb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Webb. The network helps show where Rachel Webb may publish in the future.

Co-authorship network of co-authors of Rachel Webb

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Webb. A scholar is included among the top collaborators of Rachel Webb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Webb. Rachel Webb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rwebembera, Joselyn, Rachel Webb, Andrea Beaton, et al.. (2025). Acute rheumatic fever. The Lancet. 405(10495). 2164–2178.
2.
3.
Vesty, Anna, Prachi Sharma, Natalie Lorenz, et al.. (2024). The Emergence and Impact of the M1UK Lineage on Invasive Group A Streptococcus Disease in Aotearoa New Zealand. Open Forum Infectious Diseases. 11(8). ofae457–ofae457. 6 indexed citations
4.
Cannon, Jeffrey, Julie Bennett, Anneka Anderson, et al.. (2023). Trends in penicillin dispensing during an acute rheumatic fever prevention programme. New Zealand Medical Journal. 136(1586). 84–93. 1 indexed citations
5.
Taylor, Amanda, J. Atkinson, Sally Roberts, et al.. (2023). Group A Streptococcus Primary Peritonitis in Children, New Zealand. Emerging infectious diseases. 29(11). 1 indexed citations
6.
Duffy, Eamon, Stephen Ritchie, Rachel Webb, et al.. (2023). Improved paediatric antimicrobial prescribing with a smartphone application: a before and after interventional study. Archives of Disease in Childhood. 108(11). 899–903. 4 indexed citations
7.
Best, Emma, et al.. (2023). Pediatric Invasive Meningococcal Disease, Auckland, New Zealand (Aotearoa), 2004–2020. Emerging infectious diseases. 29(4). 686–695. 6 indexed citations
8.
Bennett, Julie, William Leung, Rachel Webb, et al.. (2022). Medical Treatment for Rheumatic Heart Disease: A Narrative Review. Heart Lung and Circulation. 31(11). 1463–1470. 1 indexed citations
9.
Anderson, Anneka, et al.. (2022). Cohort profile: methodology and cohort characteristics of the Aotearoa New Zealand Rheumatic Heart Disease Registry. BMJ Open. 12(12). e066232–e066232. 1 indexed citations
10.
Best, Emma, Sara Svensson, Rachel Webb, et al.. (2022). Outcomes of adults with invasive meningococcal disease with reduced penicillin susceptibility in Auckland 2004–2017. Infection. 51(2). 425–432. 4 indexed citations
11.
Whitcombe, Alana L., Reuben McGregor, Alex James, et al.. (2021). Comprehensive analysis of SARS‐CoV‐2 antibody dynamics in New Zealand. Clinical & Translational Immunology. 10(3). e1261–e1261. 33 indexed citations
12.
Ralph, Anna P., Rachel Webb, Nicole J. Moreland, et al.. (2021). Searching for a technology-driven acute rheumatic fever test: the START study protocol. BMJ Open. 11(9). e053720–e053720. 15 indexed citations
13.
Moutasim, Karwan, et al.. (2021). Epstein - Barr virus positive Mucocutaenous ulcer presenting as medication related osteonecrosis of the jaw. SHILAP Revista de lepidopterología. 3. 100096–100096.
14.
McGregor, Reuben, Alana L. Whitcombe, Campbell R. Sheen, et al.. (2020). Collaborative networks enable the rapid establishment of serological assays for SARS-CoV-2 during nationwide lockdown in New Zealand. PeerJ. 8. e9863–e9863. 8 indexed citations
15.
Nicholson, Ross, et al.. (2019). The World Heart Federation criteria raise the threshold of diagnosis for mild rheumatic heart disease: Three reviewers are better than one. International Journal of Cardiology. 291. 112–118. 10 indexed citations
16.
Webb, Rachel, et al.. (2017). Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.. PubMed. 130(1457). 50–57. 12 indexed citations
17.
Webb, Rachel, et al.. (2017). Normal echocardiographic mitral and aortic valve thickness in children. Heart Asia. 9(1). 70–75. 8 indexed citations
18.
Webb, Rachel, Lesley Voss, Sally Roberts, et al.. (2014). Infective Endocarditis in New Zealand Children 1994–2012. The Pediatric Infectious Disease Journal. 33(5). 437–442. 19 indexed citations
19.
Reményi, Bo, Rachel Webb, Thomas L. Gentles, et al.. (2013). Improved Long-Term Survival for Rheumatic Mitral Valve Repair Compared to Replacement in the Young. World Journal for Pediatric and Congenital Heart Surgery. 4(2). 155–164. 44 indexed citations
20.
Webb, Rachel, Nigel Wilson, Diana Lennon, et al.. (2011). Optimising echocardiographic screening for rheumatic heart disease in New Zealand: not all valve disease is rheumatic. Cardiology in the Young. 21(4). 436–443. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026